The Federal Trade Commission provided a map for going after so-called drug rebate walls in a report delivered to Congress May 28 . FTC did not say it would sue over rebate walls, but two of the four commissioners, including the acting FTC chair, issued statements that are critical of the practice, and former FTC Policy Director David Balto said it’s noteworthy that the FTC report doesn’t mention potential consumer benefits from rebates and describes its recent lawsuits against exclusionary...